Literature DB >> 8563925

A comparison of the dynamic pedobarograph and EMED systems for measuring dynamic foot pressures.

B Quaney1, K Meyer, M W Cornwall, T G McPoil.   

Abstract

The purpose of this study was to compare the peak pressure and peak force values obtained from two pressure assessment systems, the Dynamic Pedobarograph and the EMED SF. Twenty-one individuals with a mean age of 31.6 years walked barefoot over both systems using a two-step data collection protocol. Peak plantar pressures and peak vertical force values were measured under the heel, central forefoot, hallux, and entire foot for both systems. The results of this study demonstrated that the EMED SF system produced larger peak pressures under the central forefoot and hallux. The Pedobarograph, on the other hand, produced greater pressures under the heel and entire foot. With respect to peak vertical forces, the Pedobarograph showed significantly greater values under the heel and central forefoot compared with the EMED SF, but were significantly lower under the hallux and entire foot.

Mesh:

Year:  1995        PMID: 8563925     DOI: 10.1177/107110079501600909

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  3 in total

1.  Remapping in the ipsilesional motor cortex after VR-based training: a pilot fMRI study.

Authors:  Eugene Tunik; Sergei V Adamovich
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

2.  Testing the proficiency to distinguish locations with elevated plantar pressure within and between professional groups of foot therapists.

Authors:  Nick A Guldemond; Pieter Leffers; Fred H M Nieman; Antal P Sanders; Nicolaas C Schaper; Geert H I M Walenkamp
Journal:  BMC Musculoskelet Disord       Date:  2006-12-01       Impact factor: 2.362

3.  Plantar forefoot pressures in psoriatic arthritis-related dactylitis: an exploratory study.

Authors:  Richard A Wilkins; Heidi J Siddle; Anthony C Redmond; Philip S Helliwell
Journal:  Clin Rheumatol       Date:  2016-05-26       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.